| ZAFETY LUG LOCK TAFCAN CONSULTING LTD.
2205709 24 Aug 2022 | on 24 Aug 2022 | Class 012 Class 012 Vehicles and Products for locomotion by land, air or water Wind turbine accessory, namely, a non-metallic connector that locks two or more nuts to each other; Vehicle lug nut accessory, namely, a non-metallic connector that locks two or more wheel nuts to each other | | | ZAFETY FLANGE LOCKS TAFCAN CONSULTING LTD.
1662756 06 Feb 2014 | on 28 Feb 2018 | Class 006 Locking system for nuts and bolts, namely, a connector that locks two or more nuts and bolts to each other Class 020 Class 020 Furniture Products | | | ZAFE TOKAI OF CANADA LTD.
1540736 17 Aug 2011 | on 07 Mar 2013 | Class 034 Class 034 Smoker's Products Utility lighters. | | | ZAFETY LUG LOCK TAFCAN CONSULTING LTD.
1392592 23 Apr 2008 | on 20 Jul 2009 | Class 012 Class 012 Vehicles and Products for locomotion by land, air or water Locking system for wheel nuts namely a connector that locks two or more wheel nuts to each other. | | | ZAFEKTIN BIOGEN IDEC MA INC.
A MASSACHUSETTS CORPORATION
1242465 22 Dec 2004 | on 10 Sep 2008 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the prevention, diagnosis and treatment of cancers; pharmaceutical preparations for use in the prevention, diagnosis and treatment of neurological disorders, namely, brain diseases, central nervous system movement disorders, multiple sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuropathic pain, neuropathy, amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, traumatic brain injury, nerve damage, demyelination, neuroocular disorders and depression; pharmaceutical preparations for use in the prevention, diagnosis and treatment of cardiovascular disorders; pharmaceutical preparations for use in the prevention, diagnosis and treatment of inflammatory disorders, namely, inflammatory bowel diseases, inflammatory skin diseases, inflammatory joint diseases, and neuroinflammatory diseases; pharmaceutical preparations for use in the prevention, diagnosis and treatment of immunoregulatory disorders, namely, autoimmune diseases, psoriasis, rheumatoid arthritis, lupus, systemic lupus erythematosus (SLE), Sjogren's syndrome, transplant rejection (graft-vs host and host-vs-graft), diabetes and fibrosis; pharmaceutical preparations for use in the prevention, diagnosis and treatment of gastrointestinal diseases. | | 
